The changes of circulating tumor cells by stereotactic radiotherapy for huge tumor due to telomescan

The changes of circulating tumor cells by stereotactic radiotherapy for huge tumor due to telomescan - The measurement of circulating tumor cells due to telomescan

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013500

Enrollment

Registered

2014-03-24

Start date

2014-03-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignancy

Interventions

Examination

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Aged over 20 Indication for stereotactic radiotherapy with huge tumor(over 5cm) Agreement with test of telomescan

Exclusion criteria

Exclusion criteria: No indication for stereotactic radiotherapy No agreement with test of telomescan

Design outcomes

Primary

Measure	Time frame
Efficacy	—

Countries

Japan

Contacts

Public ContactKenichi Kashihara

Tokyo Radiation Oncology Clinic radiology

info@troc.jp03-3529-5420

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026